Sentences with phrase «of opioid therapy»

The goal of this activity is to educate pharmacists and pharmacy technicians about identifying the risks and benefits of opioid therapy and improving its long - term safety.

A: The chronic use of opioid therapy to treat noncancer pain syndromes, such as headache and low - back pain, and arthritis, continues to be controversial.

The CDC offers several resources to help physicians in primary care practice navigate pain management and tapering of opioid therapy.

Not exact matches

Last year, the CDC recommended that patients be tested when they begin opioid therapy and that long - term users be checked annually, though it left further testing decisions to the discretion of the health practitioner.

Groups is very simple: For $ 65 a week, it offers group therapy in areas plagued by opioid addiction — targeting towns with fewer than 10,000 residents and little access to recovery programs — so people at different stages of recovery can learn from one another.

The above considerations seem to support the view that, as patients, perhaps each of us has an obligation not to request or demand opioid therapy, and to resist if offered.

None of this means, however, that we should accept further marginalization of pain and opioid therapy patients.

SiteOne is dedicated to developing novel pain therapeutics to safely, effectively and efficiently treat acute and chronic pain without the limitations of existing pain therapies, such as NSAIDs or opioids.

Among other initiatives needed are more rigorous analysis of the potency of illicit drugs being sold on the streets, information campaigns to inform the public of the analyses results and likely dangers, more treatment therapies to ease withdrawal symptoms, programs to get primary care doctors to treat and screen for addictions and wider distribution of Naltrexone, which can reverse an opioid overdose, said Ciccarone.

Hep C patients being treated for opioid addiction achieved high rates of sustained virologic response after 12 weeks of therapy with elbasvir - grazoprevir compared to those taking placebo for 12 weeks before beginning the drug treatment.

Expert guidelines recommend reducing or discontinuing long - term opioid therapy when risks outweigh the benefits, but evidence on the effects of dose reduction on patient outcomes had not been systematically reviewed.

«Countries using these measures should instead increase the availability of proven opioid - agonist therapies, such as methadone, and ensure there is adequate access to voluntary treatment programs in community settings and facilitate people with opioid addiction to seek treatment.»

People with chronic opioid use disorders are more likely to relapse and do so sooner if they are treated in a compulsory drug detention centre rather than a voluntary drug treatment centre using methadone maintenance therapy, according to the first study comparing the outcome of both approaches published in The Lancet Global Health.

The CO-STAR (Hepatitis C Patients on Opioid Substitution Therapy Antiviral Response) trial sought to evaluate the efficacy and safety of elbasvir - grazoprevir for injection drug users.

Dose reduction may improve pain, function, and quality of life for patients prescribed long - term opioid therapy for chronic pain.

Researchers at the Veterans Health Administration conducted a systematic review of 67 published studies to determine the effectiveness of strategies to reduce or discontinue long - term opioid therapy prescribed for chronic pain and the effect of dose reduction or discontinuation on important patient outcomes.

If future similar studies can further expand and eventually provide a brain - based predictive best - therapy option for individual patients, it would dramatically decrease unnecessary exposure of patients to ineffective therapies and decrease the duration and magnitude of pain suffering and opioid use, Baliki and Apkarian said.

For the 12 - week, $ 170,000 pilot project, which is funded by the National Institutes of Health (NIH) and will begin later this month, Young's team plans to recruit about 60 patients from the Ronald Reagan UCLA Medical Center who are experiencing chronic pain, are on long - term opioid therapy, and have reported other behaviors — such as drug or alcohol abuse — that put them at high risk of addiction.

The study, «Acceptance and Commitment Therapy to Manage Pain and Opioid Use after Major Surgery: Preliminary Outcomes from the Toronto General Hospital Transitional Pain Service,» is published in the Canadian Journal of Pain, by first author Muhammad Azam, Ph.D. candidate at York University and senior authors Dr. Joel Katz, Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI) and Dr. Hance Clarke, Director of the Transitional Pain Service at TGH, UHN and Clinical Researcher, TGHRI.

The interim therapy could help protect patients from the potentially fatal dangers of illegal opioid use by safely and responsibly providing medication while they await more intensive treatment.

The three regions worldwide with the highest populations of people who inject drugs, east and south - east Asia, Eastern Europe and North America, all had poor provision of needle syringe programs and opioid substitution therapy.

Just over half (52 per cent) of the countries with evidence of injecting drug use had needle syringe programs and medical treatment to encourage reductions in injecting — opioid substitution therapy — was available in less than half of all countries identified (48 per cent).

Charged with providing access to treatment programs, SAMHSA is encouraging medication - assisted therapy through the Substance Abuse Prevention and Treatment Block Grant as well as regulatory oversight of medications used to treat opioid addiction.

The article describes how HHS agencies are collaborating with public and private stakeholders to expand access to and improve utilization of medication - assisted therapies, in tandem with other targeted approaches to reducing opioid overdoses.

«Appropriate access to medication - assisted therapies under Medicaid is a key piece of the strategy to address the rising rate of death from overdoses of prescription opioids,» said co-author Stephen Cha, M.D., M.H.S., chief medical officer for the Center for Medicaid and CHIP [Children's Health Insurance Program] Services at CMS.

«When prescribed and monitored properly, medications such as methadone, buprenorphine, or naltrexone are safe and cost - effective components of opioid addiction treatment,» said lead author and NIDA director Nora D. Volkow, M.D. «These medications can improve lives and reduce the risk of overdose, yet medication - assisted therapies are markedly underutilized.»

Current therapies are largely ineffective, or can have significant side effects or potential for abuse, since most contain opioids or opiate - derivatives,» commented Jacky Smith, M.B., Ch.B., MRCP, Ph.D., lead author of the Lancet article, and professor and honorary consultant in Respiratory Medicine, University of Manchester and University Hospital Manchester NHS Foundation Trust.

«Due to increasing concerns about the risks of long - term opioid therapy for chronic pain and limited evidence as to their benefit, the Centers for Disease Control and Prevention released its Guideline for Prescribing Opioids for Chronic Pain in 2016,» said Merlin, who completed this research while at the University of Alabama at Birmingham.

For people, substitution therapies, which include slow acting opioids (methadone), opioids that produce a partial biological response (buprenorphine) or antagonists that block the opioid receptor (naloxone), are the only available treatments for opioid addiction are often leading to high rates of relapse.

The researchers» analysis revealed that opioid - related ICU admissions increased an average of more than half a percent each year over the seven - year study period and that patients admitted to ICUs as a result of overdose required increasingly intensive care, including high - cost renal replacement therapy or dialysis.

Eighty - one (94 percent) of the mothers were receiving opioid substitution therapy from the first trimester, with 17 (20 percent) relapsing into illicit drug use during the third trimester.

For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the Oct. 20 issue of JAMA Internal Medicine.

«The risk - to - benefit ratio of opioid and non-opioid therapy should be considered for all patients in determining the best initial management strategy,» said Herzig.

Alternative strategies — from physical therapy and behavioral interventions to psychological counseling and surgery — can mitigate chronic pain without the dangers of opioids.

Watkins» work with glia, for example, has indicated that long - term opioid therapy may have an effect similar to that of chronic inflammation, causing glial cells to release an excess of cytokines that actually reduce the drug's effectiveness in blocking pain.

He has authored over 300 publications, including several books, and is the recipient of numerous National Institutes of Health grants for developing integrated group therapy, as well as leading a multisite treatment study of prescription opioid dependence.

As Professor Grace says: «I hope that it'll get people to really question what the benefit of long - term opioid therapy might be.»

«This project was selected for PCORI funding for its potential to fill an important gap in our understanding of long - term opioid therapy and to give people living with chronic pain useful information to help them weigh the effectiveness and safety of their care options,» said PCORI executive director Joe Selby, MD, MPH.

There is a shortage of high - quality evidence demonstrating the safety and effectiveness of long - term opioid therapy for the management of chronic pain, and to date, no large - scale studies have assessed strategies for managing and reducing chronic opioid use in real - world clinical settings.

If an opioid is being considered for that patient, then the structure of the therapy should be very defined and very rigid, it might include any or all of the following.

Loggia said that means a lot of the focus has been placed on pain management, with patients turning to interventions such as painkillers (opioids) as well as yoga and cognitive behavioral therapy.

The task force states not only that acupuncture should be recommended before opioids are prescribed, but that it is also an effective «adjunctive therapy» in the treatment of opiate dependency.

The mechanisms by which low - level laser therapy (LLLT) decreases pain include release of endogenous opioids, changes in conduction latencies of nerves, increased cellular metabolism, increased circulation, promotion of neovascularization, decreased fibrosis formation, and reduction of inflammation.30 Feline conditions that respond well to LLLT include osteoarthritis, degenerative lumbosacral stenosis, fractures, chronic wounds, and stomatitis.31 Most cats tolerate LLLT well, as it is not painful and can be delivered in a relatively short time (FIGURE 2).31

The letter raises urgent concerns about woefully inadequate resources and the abrupt and inhumane discontinuation of medication for patients who do receive Opioid Substitution Therapy.

This policy statement from the AAP advocates a public health response to the opioid epidemic and substance use during pregnancy, and recommends: a focus on preventing unintended pregnancies and improving access to contraception; universal screening for alcohol and other drug use in women of childbearing age; knowledge and informed consent of maternal drug testing and reporting practices; improved access to prenatal care, including opioid replacement therapy; gender - specific substance use treatment programs; and improved funding for social services and child welfare systems.

Opioid substation therapy has become more available for those who are drug dependent, and continuous from prison to the community as an effective way to reduce risk of post-release death.

He says: The solution to changing the illegal or unhealthy ritualized compulsive comfort - seeking behavior of opioid addiction is to address a person's adverse childhood experiences (ACEs) individually and in group therapy; treat people with respect; provide medication assistance in the form of buprenorphine, an opioid used to treat opioid addiction; and help them find a ritualized compulsive comfort - seeking behavior that won't kill them or put them in jail.